Top Tweets for #WhyWeEKOS
Presented at #ACC25 | #REALPEII: In a propensity-matched cohort of 1,465 PE patients treated with EKOS or FlowTriever, EKOS patients had lower rates of major bleeding within 7 days & readmissions within 30 days. Real-world evidence supports EKOS safety in #PE practice. #WhyWeEKOS
Proud to announce the 300th patient enrollment in #HIPEITHO! #HIPEITHO is the first of its kind RCT trial in #PE and continues to show BSC’s commitment to #EvidenceBasedMedicine. #EKOS #WhyWeEKOS
Have you seen the results from the largest real-world and near real-time dataset evaluating advanced #PE therapies? Learn more about #REALPE here: https://t.co/xBmKhbBfHK
#WhyWeEKOS #EvidenceBasedMedicine
The results are in from the largest real-world and near real-time data set evaluating advanced #PE therapies. View here: https://t.co/CBIslLTHci #Sponsored #REALPE #WhyWeEKOS #EvidenceBasedMedicine
LIVE | Reality Check: New Perspectives on Endovascular Strategies for #PE Treatment. Learn more about The REAL-PE Analysis: https://t.co/xBmKhbBNxi
#MythShattered #WhyWeEKOS #TCT2023
Alan recounts his journey through a #pulmonaryembolism and how the #EKOS™ Endovascular System revolutionized his recovery. Hear his full story: https://t.co/BSXKz2258I #PE #WhyWeEKOS #WorldThrombosisDay
#EKOS has excellent safety outcomes and is consistently proven, making it a first-line of #PE intervention. Learn more about how Dr. Bock uses EKOS as part of his toolkit to treat PE #WhyWeEKOS
Jeremy S. Bock, MD, (@JeremySBockMD) talks about his experience with ultrasound-facilitated catheter-directed thrombolysis using the EKOS™ Endovascular System to treat pulmonary embolism. | #Sponsored by @bostonsci https://t.co/nYTRNUftUM
Today we celebrate a milestone, 100K #PE patients have been treated with #EKOS. EKOS continues to be the most studied device in the PE space. With low lytic, low blood loss, and proven results, this is #WhyWeEKOS
67y/o SOB, dizziness, DOE, RV/LV 1.9; Pulse: 127, BP: 91/62. Two 12cm EKOS+ catheters, TPA: 1mg bolus in each followed by 2mg/hr for 1 hr. Next day RV/LV 0.9; DC home 24 hours after admission. Great results w/ Optalyse protocol & EKOS+. #WhyWeEKOS #EKOS #PE @bsc_pi @bsc_vascular
Presented at #VENOUS2023 1036 #PE patients analyzed for in-hosp mortality showed #EKOS demonstrated a significantly lower rate, at any lytic dose, compared to those treated with mechanical thrombectomy. #WhyWeEKOS #EvidenceBasedMedicine https://t.co/OZbUsduGAe
Ever see data that makes you think: Hmmmm? Presented at #ISET2023 911 #PE pts analyzed for Hosp LOS showed mechanical thrombectomy had a 51% longer hospital stay than #EKOS. #WhyWeEKOS #EvidenceBasedMedicine @drksterling
(1/13) EKOS Catheter Insertion Tweetorial.
@MustafaAhmedMD @MouhamedAmr1 @Skmcelwee
My cofellows @Dr_Almubarak @DocEBROhimi
@UABCardiology @UABCVI #WIN
I am thrilled to share that #EKOS+ has fully launched & delivers 50% more ultrasound power to resolve #PE clot burden more quickly & completely. #WhyWeEKOS #EvidenceBasedMedicine Learn more about EKOS+: https://t.co/fjysHFajeB
*Only available in the US currently
Congratulations to the team at the University Medical Center of the Johannes Gutenberg University of Mainz for enrolling the first #HIPEITHO patient in Germany! @uni_mainz_eng @bostonsci @bsc_pi @docmrjaff @krosenfieldMD @drandrewsharp @Erik_Klok_MD @fniainle #WhyWeEkos
“We were that close – just a day or so – from getting on an airplane, getting on a cruise. I wouldn’t have survived. There’s no way. And to have the kind of help available right here near our home meant the world to us.”
STORY: https://t.co/EcYjIAkEoO
#HIPEITHO #clinicaltrials
Congratulations to the team at @UZH_en for enrolling the first #HIPEITHO patient in Switzerland! #EvidenceBasedMedicine #WhyWeEkos @docmrjaff @bsc_pi @fniainle @drandrewsharp @Erik_Klok_MD @krosenfieldMD @bostonsci
Welcome to #HIPEITHO @Erik_Klok_MD and study team at @LUMC_Leiden! The first site to open in The Netherlands! We look forward to your first enrollment! @bostonsci @bsc_pi @docmrjaff @drandrewsharp @fniainle @krosenfieldMD #Ekos #WhyWeEkos #EvidencedBasedMedicine
Attention HI-PEITHO study teams! Check your email for our July Newsletter! This edition includes links to view the mobile app training & series of investigator meetings + a spotlight on Professor Irene Lang’s first enrollment at Vienna General Hospital! #HIPEITHO #EKOS #WhyWeEKOS
With the current global #contrastshortage, Dr. @AnasSafadi8 shares his contrast-free technique using CTA as a roadmap for #EKOS catheter placement for the treatment of #PE. Learn more in this 10-minute video: https://t.co/Yo3t8o6WGq #WhyWeEKOS
EKOS is a safe, repeatable and reliable treatment that dissolves thrombus quickly with low lytic, low blood loss and low trauma – resulting in proven long-term outcomes. #evidencebasedmedicine #whyweEKOS #pulmonaryembolism #ekostherapy #BSCEMEA https://t.co/OO1bXX5BFY
Last Seen Hashtags on Sotwe
gothicteen
Seen from United States
Omegle() + filter:native_video
Seen from Brazil
ProperSpendingPowerIn
Seen from United States
omegle video**
Seen from Turkey
momsonn()()()() filter:videos
Seen from Germany
culona
nolimits(((())))+filter:native_video
Seen from Israel
husbands
Seen from Indonesia
ガリ傷
Seen from United States
ometv
Seen from Argentina
Most Popular Users
Elon Musk 
@elonmusk
241.6M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.1M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.8M followers
Taylor Swift
@taylorswift13
83.8M followers
Lady Gaga
@ladygaga
75.2M followers
Virat Kohli
@imvkohli
73M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66M followers
Bill Gates
@billgates
65M followers
Selena Gomez
@selenagomez
62.9M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers